Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial

Nizar S. Abdelfattah, Mayss Al-Sheikh, Sean Pitetta, Ahmed Mousa, Srini Vas R. Sadda, Charles C. Wykoff, Charles C. Wykoff, Daniel E. Croft, David M. Brown, Rui Wang, John F. Payne, Lloyd Clark, Srini Vas R. Sadda, Matthew S. Benz, Eric Chen, Richard H. Fish, David L. Johnson, Rosa Y. Kim, James C. Major, Ronan E. O'MalleyAmy C. Schefler, Ankoor R. Shah, Sushma K. Vance, John A. Wells, Tien P. Wong

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 'Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences